VERAPAMIL HYDROCHLORIDE · GLENMARK PHARMS LTD
Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1. Angina at rest including: – Vasospastic (Prinzmetal’s variant) angina – Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina) Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS; Accessory bypass tract ) 2.
Details
- Status
- Prescription
- First Approved
- 1981-08-12
- Routes
- ORAL, INJECTION, INTRAVENOUS
- Dosage Forms
- TABLET, EXTENDED RELEASE, TABLET, INJECTABLE, SOLUTION, CAPSULE, EXTENDED RELEASE
Companies
VERAPAMIL HYDROCHLORIDE Approval History
What VERAPAMIL HYDROCHLORIDE Treats
5 indicationsVERAPAMIL HYDROCHLORIDE is approved for 5 conditions since its original approval in 1984. These indications span multiple therapeutic areas including oncology, immunology, and more.
VERAPAMIL HYDROCHLORIDE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in VERAPAMIL HYDROCHLORIDE's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications VERAPAMIL HYDROCHLORIDE treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to VERAPAMIL HYDROCHLORIDE
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
4 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT03013933 | 16414 NCI-2016-02062, 16414 | Ph 1 | completed | Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma |
| NCT03098680 PRIME | PRIME (A094136) | Ph 1 | terminated | A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems |
| NCT07706075 | POFH/05-2026/ E. Medicine/ 10 | Ph 4 | not yet recruiting | Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation) |
| NCT07688070 | 2390110 | Ph 2 | not yet recruiting | Verapamil Effect in Cystic Fibrosis-related Dysglycemia |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
VERAPAMIL HYDROCHLORIDE FDA Label Details
Indications & Usage
FDA Label (PDF)Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1. Angina at rest including: – Vasospastic (Prinzmetal’s variant) angina – Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina) Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS; Accessory bypass tract ) 2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia Essential hypertension: Verapamil is indicated fo...
Looking for the branded version?
VERELAN PM
Full clinical data, patents, trials, and competitive landscape for verapamil hydrochloride.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.